Yahoo Finance • last month
WESTBROOK, Maine, September 30, 2024--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, befor... Full story
Yahoo Finance • last month
Key Insights The projected fair value for IDEXX Laboratories is US$442 based on 2 Stage Free Cash Flow to Equity With US$507 share price, IDEXX Laboratories appears to be trading close to its estimated fair value Our fair value estimate i... Full story
Yahoo Finance • 2 months ago
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. In a perfect world, we'd like to see a company investing more capital into its business and ideally... Full story
Yahoo Finance • 3 months ago
Market whiplash Last week started out with disappointing results from McDonald's (NYSE:MCD) and Microsoft (NASDAQ:MSFT), in the middle of the week both Fed commentary which nearly confirmed a September rate cut and outstanding Meta (NASDA... Full story
Yahoo Finance • 4 months ago
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The strategy’s benchmark switched from the Russell 3000... Full story
Yahoo Finance • 4 months ago
Many IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable to know whether insiders... Full story
Yahoo Finance • 6 months ago
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has... Full story
Yahoo Finance • 8 months ago
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite rose 11.00% net of fees in the fourth quarter, c... Full story
Yahoo Finance • 9 months ago
Many IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether insiders are buying versus if they s... Full story
Yahoo Finance • 9 months ago
Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits WESTBROOK, Maine, Feb. 15, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announ... Full story
Yahoo Finance • 9 months ago
George Fennell, SVP, Chief Revenue Officer of IDEXX Laboratories Inc (NASDAQ:IDXX), executed a sale of 8,198 shares in the company on February 8, 2024, according to a SEC Filing. Warning! GuruFocus has detected 4 Warning Sign with IDXX.... Full story
Yahoo Finance • 9 months ago
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on the bright side, you can make far more than 100% on a really good stock. Long term IDEXX Laboratories, I... Full story
Yahoo Finance • 9 months ago
Revenue: Q4 revenue increased by 9% to $902 million, with full year revenue up by 9% to $3,661 million. Earnings Per Share (EPS): Q4 EPS rose by 13% to $2.32, while full year EPS grew by 25% to $10.06. Operating Margin: Q4 operating margin... Full story
Yahoo Finance • 10 months ago
Fundsmith LLP, an investment management company based in London, released its “Fundsmith Equity Fund” 2023 yearly update. A copy of the same can be downloaded here. In 2023, the Fundsmith Equity Fund rose +12.4 compared to a 16.8% return f... Full story
Yahoo Finance • 10 months ago
Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare... Full story
Yahoo Finance • 10 months ago
AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases The global launch of the IDEXX inVue Dx analyzer will begin in late 2024 WESTBROOK, Mai... Full story
Yahoo Finance • 11 months ago
In a notable insider transaction, Executive Vice President James Polewaczyk has parted with 11,636 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, software, and water microbiology testing. The sale, whic... Full story
Yahoo Finance • 11 months ago
WESTBROOK, Maine, December 07, 2023--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events: Thursday, January 4, 2024, 1:30 p... Full story
Yahoo Finance • 11 months ago
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investments often have little probability of ever... Full story
Yahoo Finance • 12 months ago
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite declined 8.01% net of fees in the third quarter,... Full story